✦ LIBER ✦

DEFECTS OF IMMUNE INTERFERON SECRETION AND NATURAL KILLER ACTIVITY IN PATIENTS WITH IMMUNOLOGICAL DISORDERS

✍ Scribed by Virelizier, Jean-Louis; Lipinski, Marc; Tursz, Thomas; Griscelli, Claude

Book ID: 121962494
Publisher: The Lancet
Year: 1979
Tongue: English
Weight: 286 KB
Volume: 314
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(79)92098-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natural killer and killer cell activitie

Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production

✍ Marc Lipinski; Jean-Louis Virelizier; Thomas Tursz; Claude Griscelli 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Defective interferon-augmented natural k

Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma

✍ Ch. Müller; H. Pehamberger; M. Binder; C. C. Zielinski 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 341 KB

Decreased natural killer (NK) activity i

Decreased natural killer (NK) activity in patients with myeloproliferative disorders

✍ Paul Froom; Ester Aghai; Amalia Kinarty; Nitza Lahat 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 2 views

Natural Killer Cell Activity in Patients

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

✍ Uchida, A.; Maida, E.M.; Lenzhofer, R.; Micksche, M. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Natural killer cells activity in patient

Natural killer cells activity in patients with multiple sclerosis given α interferon

✍ George P. A. Rice; Paolo Casali; Thomas C. Merigan; Michael B. A. Oldstone 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Defective function of lymphokine-activat

Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma

✍ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i